Sign inGet started

Newcomer Lee Nisley

Insider CIK 1788981 · CHRS Director · MYGN Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CHRS Coherus Oncology, Inc. A Award deriv2026-06-052026-06-0960,000— $060,000SEC↗
CHRS Coherus Oncology, Inc. A Award2026-06-052026-06-0930,000— $030,000SEC↗
MYGN MYRIAD GENETICS INC A Award2026-06-042026-06-0559,701— $0191,842SEC↗
CHRS Coherus Oncology, Inc. A Award deriv2025-06-122025-06-13112,000— $0112,000SEC↗
MYGN MYRIAD GENETICS INC A Award2025-06-052025-06-0649,796— $0132,141SEC↗
MYGN MYRIAD GENETICS INC A Award2024-06-062024-06-0715,695— $082,345SEC↗
CHRS Coherus BioSciences, Inc. A Award deriv2024-06-032024-06-05112,000— $0112,000SEC↗
MYGN MYRIAD GENETICS INC S Sale2024-05-132024-05-156,200$25.30 $156.9K66,650SEC↗
CHRS Coherus BioSciences, Inc. A Award deriv2023-06-072023-06-0938,250— $038,250SEC↗
MYGN MYRIAD GENETICS INC A Award2023-06-012023-06-0215,151— $072,850SEC↗
MYGN MYRIAD GENETICS INC A Award2022-06-022022-06-0317,275— $057,699SEC↗
CHRS Coherus BioSciences, Inc. A Award deriv2022-02-022022-02-0454,000— $054,000SEC↗
MYGN MYRIAD GENETICS INC A Award2021-06-032021-06-0412,848— $040,424SEC↗
MYGN MYRIAD GENETICS INC A Award2020-12-042020-12-0715,889— $027,576SEC↗
MYGN MYRIAD GENETICS INC A Award2019-12-052019-12-0611,687— $011,687SEC↗